MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Dr Martens narrows loss amid cost-cutting measures

ALN

Dr Martens on Thursday reported a narrowed interim loss as selling and administrative expenses fell and a small decrease in revenue was offset by growth in the Americas.

Shares in Dr Martens fell 9.1% to 72.83 pence on Thursday morning in London.

The London-based bootmaker said pretax loss for the 26 weeks ended September 28 narrowed 62% to £11.0 million from £28.7 million.

This was driven by a 6.3% drop in selling and administrative expenses to £208.8 million from £222.8 million. Dr Martens noted it ‘continued to embed a culture of tight cost control’ in the first half to help improve its bottom line.

Revenue fell 0.8% to £322.0 million from £324.6 million. There was a 1.8% increase in revenue for the Americas, while EMEA - the company’s biggest segment - and APAC revenue saw drops of 2.3% and 1.9% respectively.

The company said it has focused on improving the quality of its revenue by increasing the full price mix and reducing the promotion time of seasonal lines and the extent of discounts offered.

Dr Martens declared an interim dividend of 0.85 pence per shape, flat year-on-year.

Looking ahead, the company said it is trading in line with expectations. It noted that its sell-side adjusted pretax profit consensus range is between £53 million to £60 million.

‘These figures did not include any impact from tariffs, and we remain comfortable in achieving this range on that basis. We can now give guidance on the impact of tariffs on FY26, and they represent a high single-digit [million pound] headwind. Given the timing of our mitigation actions, we expect to offset roughly half of this impact’, Dr Martens said.

For financial 2026, the company expects to open 20 to 25 new stores. It added it expects £20 million in capital expenditure, having changed from £20m to £25m previously, as well as net finance costs of around £25 million, changed from £25 million to £27 million.

Chief Executive Ije Nwokorie said: ‘This strategic progress, as well as the benefits from the cost action plan delivered last year and our continued focus on cost management, is delivering a meaningful improvement in our financial performance including a continued reduction in net bank debt.

‘While the marketplace remains uncertain and consumers are cautious, and our biggest trading weeks are ahead, we are confident in our plans for the year. I am laser-focused on execution and setting the business up for growth in the coming years.’

Copyright 2025 Alliance News Ltd. All Rights Reserved.